Loading clinical trials...
Loading clinical trials...
Multicentre, Randomized, Multi-arm Trial Comparing the Efficacy and Safety of Adalimumab, Anakinra and Tocilizumab in Subjects With Non-infectious Refractory Uveitis RUBI: Refractory Uveitis BIotherapies
Conditions
Interventions
Anakinra
Tocilizumab
+1 more
Locations
27
France
Hopital la pitié salpetriere - Médecine interne 1
Paris, paris, France
Hopital Avicenne - CRC
Bobigny, France
Hopital Avicenne - Ophtalmologie
Bobigny, France
Hopital Avicenne- Médecine interne
Bobigny, France
Hopital Pellegrin
Bordeaux, France
Hopital Saint André - Médecine interne
Bordeaux, France
Start Date
June 29, 2017
Primary Completion Date
October 29, 2021
Completion Date
January 29, 2022
Last Updated
September 16, 2025
NCT07218770
NCT05486468
NCT02706704
NCT06916104
NCT06431373
NCT07262437
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions